Go to main content
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Cite
Citation

Files

Abstract

The ability of tumors to induce immunosuppression and inhibit the cytolytic function of tumor-infiltrating lymphocytes (TIL) is a major obstacle to creating effective immunotherapies for cancer patients. The levels of galectin-3 (Gal-3) protein, which contribute to the immunosuppression, are increased during tumor progression in many cancers. Gal-3 contributes to immunosuppression by inducing M2 (wound healing) polarization of tumor-associated macrophages and playing a role in the survival and metastasis of cancer cells.

Details

PDF

Statistics

from
to
Export
Download Full History